Načítá se...
A Radium-223 Microgenerator from Cyclotron-Produced Trace Actinium-227
The alpha particle emitter Radium-223 dichloride ((223)RaCl(2)) has recently been approved for treatment of late-stage bone metastatic prostate cancer. There is considerable interest in studying this new agent outside of the clinical setting, however the supply of (223)Ra is limited and expensive. W...
Uloženo v:
| Vydáno v: | Appl Radiat Isot |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5136344/ https://ncbi.nlm.nih.gov/pubmed/27835737 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apradiso.2016.10.015 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|